![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 08, 2014 8:02:03 AM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1359]
Development and Regulation of Abuse-
Deterrent Formulations of Opioid
Medications; Public Meeting
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice of public meeting;
request for comments.
http://www.gpo.gov/fdsys/pkg/FR-2014-09-23/pdf/2014-22514.pdf
It's steps in the right direction of stopping the scourge on our people of such drugs, but I have one comment only - The FDA must publish the Final Order of its own initiated proposal to create the new classification of PEMF/SWT devices and then apply lightning speed, like <30 days, to approving subsequent applications for such devices to be sold OTC in our country. Why? Because, after years of hunting, there are no negative side-effects for these devices when inside the specifications contemplated, yet it has been established there is substantial efficacy in managing chronic pain. With FDA approval, the phenomenon will spread globally. Let's move on people! American ingenuity, get 'er done!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM